532039 — Zenotech Laboratories Balance Sheet
0.000.00%
- IN₹3.79bn
- IN₹3.51bn
- IN₹430.47m
Annual balance sheet for Zenotech Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 26 | 25.7 | 118 | 197 | 279 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 45.6 | 42.8 | 33.2 | 54.6 | 74.5 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 73.5 | 73.7 | 163 | 262 | 360 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 764 | 712 | 704 | 675 | 644 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 858 | 941 | 1,009 | 1,062 | 1,110 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 149 | 156 | 166 | 135 | 126 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 374 | 234 | 186 | 157 | 149 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 484 | 706 | 823 | 905 | 961 |
Total Liabilities & Shareholders' Equity | 858 | 941 | 1,009 | 1,062 | 1,110 |
Total Common Shares Outstanding |